Sacré, A.; Barthélémy, P.; Korenbaum, C.; Burgy, M.; Wolter, P.; Dumez, H.; Lerut, E.; Loyson, T.; Joniau, S.; Oyen, R. Prognostic Factors in Second-Line Targeted Therapy for Metastatic Clear-Cell Renal Cell Carcinoma After Progression on an Anti-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor. AO 2016, 55, 329-340.